scispace - formally typeset
X

Xiaoyang Wan

Researcher at Huazhong University of Science and Technology

Publications -  26
Citations -  430

Xiaoyang Wan is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Zebrafish & Medicine. The author has an hindex of 10, co-authored 23 publications receiving 287 citations. Previous affiliations of Xiaoyang Wan include Chinese Academy of Sciences & Tongji Medical College.

Papers
More filters
Journal ArticleDOI

Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model.

TL;DR: In an HBV-immunocompetent mouse model, non-alcoholic hepatic steatosis inhibited HBV replication, as indicated by the reduction of HBV DNA andHBV-related antigens.
Journal ArticleDOI

Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1

TL;DR: Excessive CAV1 is established as a mediator of the predisposition to podocyte injury because of loss of EMP2, suggesting CAV 1 could be a novel therapeutic target in nephrotic syndrome and podocytes injury.
Journal ArticleDOI

GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway.

TL;DR: It is confirmed that GADD45B was significantly upregulated during the early phase of podocyte injury in cultured human podocytes and that podocyte apoptosis induced by TGF-β and puromycin aminonucleoside was aggravated by Gadd45B overexpression but ameliorated by shRNA-mediated GADD 45B knockdown.
Journal ArticleDOI

Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.

TL;DR: AKI in ACLF patients is more likely associated with structural kidney injury, and is more progressive, with a poorer response to terlipressin treatment and a worse prognosis than that in DC patients.